Apellis Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Apellis Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • Apellis Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $444K, a 5.46% increase year-over-year.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.78M, a 14.9% increase from 2022.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2022 was $1.55M, a 12.5% increase from 2021.
  • Apellis Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.38M, a 116% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $444K +$23K +5.46% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $421K +$44K +11.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $377K +$95K +33.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $282K +$197K +232% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 $85K +$44K +107% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q1 2019 $41K Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.